To examine the risk of cervical cancer in a large national cohort of military veteran women, followed up for up to 30 years.
Results
During the follow-up period 1981-2012, there were 18 (0.34%) cases of cervical cancer in the veteran women compared with 81 (0.39%) in the non-veterans. The difference was not statistically significant overall (adjusted hazard ratio (HR) 0.95, 95% CI 0.57-1.59). When analysed by year of birth, veteran women born in 1958 and earlier had a non-significantly higher risk than non-veterans (adjusted HR 1.24, 95% CI 0.68-2.26), whilst veteran women born after 1958 had a non-significant reduction in risk (adjusted HR 0.51, 95% CI 0.18-1.44).
Conclusion
Women born after 1958 who have served in the Armed Forces are at reduced risk of cervical cancer compared with women who have never served, and compared with older veteran women. Small numbers of cases precluded statistical significance. The change in risk pattern in veteran women coincided with the introduction of cervical screening in the Armed Forces, which predated the UK national programme, and provides evidence for the long-term
KEY/EDUCATIONAL MESSAGES
• Overall, UK military veteran women are at no greater risk of cervical cancer than non-veteran women.
• Veteran women born 1945-1958 had a higher risk than non-veterans, but the reverse is true of veterans born since 1959 although the difference did not reach statistical significance.
• The early introduction of cervical cytology in the Armed Forces (which predated the NHS programme), proactive sexual health promotion, and high uptake of screening, may be responsible for the changing pattern.
INTRODUCTION
Cervical cancer is the third commonest cancer in women worldwide, although the implementation of screening programmes in developed countries has had a major impact and in the UK, it ranks only 11 th , accounting for 2% of all new cancers in women. The peak incidence is in the 4 th decade of life although there is a smaller peak in the 9 th decade.
There is a crude incidence in Scotland of 11 per 100,000, with a lifetime risk of 1 in 112. [1, 2] By 2002/04, there had been a 49% reduction in incidence compared with 1985/87, prior to the introduction of the UK national screening programme. More recently, an increase in incidence, greatest in women aged 20-34, has been reported and has been mirrored in other countries. [3, 4] Cervical cytology as a screening tool was developed in the 1920s by Papanicolaou but it was not until 1947 that the details of the procedure for sampling the cervix were published. [5] Screening was introduced on an ad hoc basis in the UK in 1967, [3] 
METHODS

Design and participants
The Scottish Veterans Health study is a retrospective cohort study that comprises all 56,570 
Statistical analysis
Cox proportional hazard models were used to examine the association between veteran status and cumulative risk of cervical cancer, using age as the time dependent variable, age at first record of cervical cancer as the failure time and age at death (if no cervical cancer) as the censor time. Cox proportionality assumptions were tested using methodology based on Schoenfeld residuals. [18] The a priori rejection level was set at 0.05. The models were run univariately and then repeated adjusting for the potential confounding effect of SES quintile.
The analyses were repeated stratifying by year of birth to examine potential birth cohort effects. All analyses were performed using Stata v12.1 (©1985-2011 StataCorp). There was one death from cervical cancer in the veterans (4.4 per 1,000 woman-years), equating to a crude case-fatality rate of 5.6%, compared with 8 deaths in the non-veterans (8.2 per 1,000 woman-years), equating to a crude case fatality rate of 9.9%.
RESULTS
After
DISCUSSION
Main findings
Data from the Scottish Veterans Study has demonstrated that overall, military veteran women were at no greater risk of cervical cancer than women who had never served, but the risk has changed over time. Veteran women in the earlier birth cohort (1945) (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) demonstrated a non-significantly higher risk of cervical cancer than non-veterans, but there was a greater reduction in risk in veterans born after 1958 than in matched non-veteran women. However, absolute numbers of cases were small and the difference did not achieve statistical significance.
Interpretation
The majority of women born after 1958 joined the Services from 1976 onwards, at a time when the military cervical cytology service was well established and available to all women registered with an HM Forces primary care practice. Although screening was always subject to informed consent, anecdotal recollections suggest that refusal was almost unknown. The results of this study indicate that the widespread acceptance of screening reported by Zaklama and Birkett [8] was highly effective in preventing later cervical cancer in veterans, whether by timely treatment and follow-up of pre-invasive disease or by inculcating a culture of regular screening from an early age in a group who, as fit young Servicewomen, were highly motivated to maintain their health.
The majority of Servicewomen in our cohort left the Armed Forces after a short period of service. Thus, for veterans resident in Scotland, ascertainment of cases of cervical cancer, with a peak incidence in the 4 th decade, is likely to be reasonably complete, with few cases There was a non-significant decline in incidence in white military women, compared with a significant decline in national incidence. [22] Data from our study indicate that military service reduces the risk of cervical cancer in women born after 1958, the incidence of cervical cancer in this group having fallen further than in the non-veteran women.
Previous Studies
Strengths and limitations
The strengths of the present study are that it was based on a large cohort covering the whole of Scotland over more than 30 years of follow-up. The majority of the women reached the peak age for cervical cancer incidence during the study follow-up period, even if they had been serving in the Armed Forces. Since the diagnosis of cervical cancer was taken from hospital admission, cancer registration and death records, it is likely to be both reliable and reasonably complete in respect of those events occurring within Scotland. The use of record linkage to analyse individual level data directly derived from health records allowed a robust cohort study design to be employed. We were able to adjust the results for socioeconomic status. For women who are military veterans, we have been able to access follow-up data from the Gulf Veterans study which has provided a further estimate of cervical cancer rates in Servicewomen and veterans.
Scotland, which could not be quantified, and the lack of any follow-up data prior to 1 January 1981 although as the oldest of the cohort were only aged 36 years at that date, the number having been diagnosed with cervical cancer by then is likely to be small. Women with Reserve service only were not separately identifiable in the electronic record and were therefore included with the non-veterans. They receive screening from the NHS and the effect will have been to reduce the apparent magnitude of any differences associated with military service. Because of very small numbers of cases, the results, although indicating a difference between veterans and non-veterans and a changing pattern over time, did not achieve statistical significance. 
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